Table 4 Adjusted odds ratios of prior herpes zoster among patients with head and neck cancer (HNC) vs. controls by the occurrence timing of prior herpes zoster.
From: Associations of head and neck cancers with herpes zoster in the preceding five years
Presence of prior herpes zoster | Occurrence timing of herpes zoster prior to the index date | |||||
|---|---|---|---|---|---|---|
Within one year | Within two years | Within three years | ||||
Patients with HNCs n, % | Controls n, % | Patients with HNCs n, % | Controls n, % | Patients with HNCs n, % | Controls n, % | |
Yes | 156, 1.70% | 240, 0.65% | 312, 3.39% | 523, 1.42% | 475, 5.17% | 799, 2.17% |
ORa (95% CI) | 2.628c (2.145 ~ 3.219) | 1.00 | 2.436c (2.113 ~ 2.808) | 1.00 | 2.454c (2.185 ~ 2.755) | 1.00 |
Adjustedb OR (95% CI) | 2.648c (2.161 ~ 3.246) | 1.00 | 2.461c (2.134 ~ 2.839) | 1.00 | 2.492c (2.218 ~ 2.801) | 1.00 |
